Cargando…

Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review

BACKGROUND: Despite ongoing efforts aimed to improve treatment engagement for people with substance-related disorders, evidence shows modest rates of utilization as well as client-perceived barriers to care. Patient-centered care (PCC) is one widely recognized approach that has been recommended as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marchand, Kirsten, Beaumont, Scott, Westfall, Jordan, MacDonald, Scott, Harrison, Scott, Marsh, David C., Schechter, Martin T., Oviedo-Joekes, Eugenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739978/ https://www.ncbi.nlm.nih.gov/pubmed/31511016 http://dx.doi.org/10.1186/s13011-019-0227-0

Ejemplares similares

Patient-centred care for addiction treatment: a scoping review protocol
por: Marchand, Kirsten, et al.
Publicado: (2018)

Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2020)

Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment
por: Palis, Heather, et al.
Publicado: (2021)

The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2015)

The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC
por: Dobischok, Sophia, et al.
Publicado: (2023)

Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder
por: Palis, Heather, et al.
Publicado: (2017)

Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2019)

The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder()
por: Palis, Heather, et al.
Publicado: (2018)

Changes in daily dose in open-label compared to double-blind: The role of clients’ expectations in injectable opioid agonist treatment
por: Blawatt, Sarin, et al.
Publicado: (2023)

The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users
por: Marchand, Kirsten, et al.
Publicado: (2015)

Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review
por: Adams, Alison, et al.
Publicado: (2023)

The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review
por: Adams, Alison, et al.
Publicado: (2023)

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2012)

Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency
por: Marchand, Kirsten I, et al.
Publicado: (2011)

Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2021)

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
por: Palis, Heather, et al.
Publicado: (2021)

Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study
por: Dobischok, Sophia, et al.
Publicado: (2022)

“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises
por: Jaffe, Kaitlyn, et al.
Publicado: (2023)

Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2014)

A chance to stop and breathe: participants’ experiences in the North American Opiate Medication Initiative clinical trial
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2014)

Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2023)

Feasibility of Applying the Life History Calendar in a Population of Chronic Opioid Users to Identify Patterns of Drug Use and Addiction Treatment
por: Fikowski, Jill, et al.
Publicado: (2014)

NAOMI: The trials and tribulations of implementing a heroin assisted treatment study in North America
por: Gartry, Candice C, et al.
Publicado: (2009)

A critical analysis of user satisfaction surveys in addiction services: opioid maintenance treatment as a representative case study
por: Trujols, Joan, et al.
Publicado: (2014)

Conceptualization of patient‐centered care in Latin America: A scoping review
por: Klimesch, Anne, et al.
Publicado: (2023)

Substance use and substance use disorder, in relation to COVID-19: protocol for a scoping review
por: Kumar, Navin, et al.
Publicado: (2021)

The Cedar Project: resilience in the face of HIV vulnerability within a cohort study involving young Indigenous people who use drugs in three Canadian cities
por: Pearce, Margo E., et al.
Publicado: (2015)

Substance, use in relation to COVID-19: A scoping review
por: Kumar, Navin, et al.
Publicado: (2022)

Disseminating research findings: what should researchers do? A systematic scoping review of conceptual frameworks
por: Wilson, Paul M, et al.
Publicado: (2010)

“It feels like I’m coming to a friend’s house”: an interpretive descriptive study of an integrated care site offering iOAT (Dr. Peter Centre)
por: Dobischok, Sophia, et al.
Publicado: (2023)

Social Verification Theory: A New Way to Conceptualize Validation, Dissonance, and Belonging
por: Hillman, James G., et al.
Publicado: (2022)

Naturalistic exploratory study of the associations of substance use on ADHD outcomes and function
por: MacDonald, Benjamin, et al.
Publicado: (2021)

The Classification of Substance Use Disorders: Historical, Contextual, and Conceptual Considerations
por: Robinson, Sean M., et al.
Publicado: (2016)

Prescription de psychostimulants aux personnes présentant un trouble lié à l’utilisation de stimulants dans le continuum de soins au Canada
por: Palis, Heather, et al.
Publicado: (2023)

Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada
por: Palis, Heather, et al.
Publicado: (2023)

Conceptualizing citizenship in dementia: A scoping review of the literature
por: O’Connor, Deborah, et al.
Publicado: (2022)

Major depression epidemiology from a diathesis-stress conceptualization
por: Patten, Scott B
Publicado: (2013)

Incidence in pharmacoepidemiology: A conceptual framework for incidence of a single substance or group of substances with statins as an example
por: Hoffmann, Mikael, et al.
Publicado: (2022)

Interprofessional online learning for primary healthcare: findings from a scoping review
por: Reeves, Scott, et al.
Publicado: (2017)

Letter to the Editor on “COVID-19 Infection in Men on Testosterone Replacement Therapy”
por: MacDonald, Scott, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t50g37vjtk1ngof4cgoql628n4